Imelda Hospital

Running trials

• Recruiting

  STRATHEP: AI-Driven Treatment Stratification for Advanced Hepatocellular Carcinoma

  NCT07863258· Source

• Recruiting

  A Study to Assess Change in Disease Symptoms in Adult Participants With Advanced Parkinson Disease Using Subcutaneous Foslevodopa/Foscarbidopa in Belgium

  NCT07382440· Source

• Recruiting

  Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease in Belgium

  NCT06581042· Source

• Recruiting

  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  NCT05485961· Phase 2/3· Source

• Active, not recruiting

  Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy

  NCT05952206· Phase 3· Source

• Active, not recruiting

  Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients

  NCT05705973· Source

• Recruiting

  Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)

  NCT05246813· Source

• Recruiting

  The PIONEER-IV Study is Comparing Clinical Outcomes Between Angiography-derived Physiology Guidance to Usual Care in an All-comers PCI Population With Unrestrictive Use of the HT Supreme Sirolimus-eluting Stent

  NCT04923191· Source

• Recruiting

  Resting Full-cycle Flow Ratio (RFR) Versus Angiography to Guide Revascularization Strategy in Patients Undergoing Coronary Artery By-pass Grafting (CABG)

  NCT04375306· Source

• Active, not recruiting

  Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices

  NCT03366545· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease3 recruiting
• Chronic kidney disease1 recruiting
• Crohn's disease1 recruiting
• Liver and biliary tract cancer1 recruiting
• Osteoporosis1 recruiting
• Parkinson disease1 recruiting
• Ulcerative colitis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer

  NCT05983367· Phase 2· Source

• Completed

  ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASA

  NCT05992142· Phase 4· Source

• Completed

  CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple Sclerosis

  NCT05671055· Source

• Terminated

  The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

  NCT04985968· Phase 3· Source

• Completed

  An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)

  NCT04941768· Source

• Completed

  Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy

  NCT04813627· Source

• Terminated

  Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis

  NCT04883840· Phase 2/3· Source

• Completed

  A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

  NCT01848561· Source

Trial sites

• Bonheiden - HOSP Imelda0 trials
• Imelda Hospital2 trials
• Imelda Hospital Bonheiden1 trial
• Imelda Ziekenhuis12 trials
• Imelda Ziekenhuis Bonheiden0 trials
• Imelda Ziekenhuis Bonheiden (Site 0301)0 trials
• Imelda Ziekenhuis /ID# 1274971 trial
• Imelda Ziekenhuis /ID# 1574030 trials
• Imelda Ziekenhuis /ID# 2111010 trials
• Imelda Ziekenhuis /ID# 2570820 trials
• Imelda Ziekenhuis /ID# 2659950 trials
• Imelda Ziekenhuis /ID# 2686311 trial
• Imelda Ziekenhuis /ID# 2693690 trials
• Imelda Ziekenhuis /ID# 2793330 trials
• Imelda Ziekenhuis /ID# 2794361 trial
• Imeldaziekenhuis (Imelda Hospital)0 trials